PharmAla Biotech Holdings, Inc. is a biotechnology company, which engages in the research, development, and manufacturing of MDXX class molecules, including MDMA. It also provides manufacturing of active pharmaceutical ingredient (API) and drug product formulation. The company was founded on January 12, 2021 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of PharmAla Biotech Holdings Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PharmAla Biotech Holdings Inc. market cap is $11.04M.
What is the 52-week high for PharmAla Biotech Holdings Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PharmAla Biotech Holdings Inc. 52 week high is $0.2563 as of September 06, 2025.
What is the 52-week low for PharmAla Biotech Holdings Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PharmAla Biotech Holdings Inc. 52 week low is $0.0498 as of September 06, 2025.
What is PharmAla Biotech Holdings Inc. stock price today?
PharmAla Biotech Holdings Inc. stock price today is $0.084.
What was PharmAla Biotech Holdings Inc. stock price yesterday?
PharmAla Biotech Holdings Inc. stock price yesterday was $0.1045.
What is the PE ratio of PharmAla Biotech Holdings Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PharmAla Biotech Holdings Inc.’s P/E ratio is -7.06.
What is the Price-to-Book ratio of PharmAla Biotech Holdings Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PharmAla Biotech Holdings Inc. P/B ratio is 5.5145.
What is the 50-day moving average of PharmAla Biotech Holdings Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PharmAla Biotech Holdings Inc. 50-day moving average is $0.0817.
